Influenza B Virus anticorps

N° du produit ABIN316658

L’anticorps anti-Influenza B Virus Monoclonal Souris est utilisé pour la détection de Influenza B Virus dans des échantillons de Influenza B Virus. Il a été validé pour IF et IHC (fro).

Aperçu rapide pour Influenza B Virus anticorps (ABIN316658)

Antigène: Influenza B Virus

Reactivité: Influenza B Virus

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Inconjugué

Application: Immunofluorescence (IF), Immunohistochemistry (Frozen Sections) (IHC (fro))

Clone: 1131

Détail du produit

Attributs du produit: Synonyms: Influenza B Nucleoprotein NP

Purification: Purified IgG prepared by affinity chromatography on Protein A

Immunogène: Influenza B virus preparation

Isotype: IgG2b

Information d'application

Indications d'application: Immunohistochemistry on frozen sections. Immunofluorescence.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Stockage

Concentration: 1.0 mg/mL

Buffer: PBS containing 0.09 % Sodium Azide (NaN3) as preservative

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C/-20 °C

Stockage commentaire: Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer. Avoid repeated freezing and thawing.
Shelf life: one year from despatch. Caution: (A full Health and Safety assessment is available upon request) This product containsSodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled bytrained staff only.

Date de péremption: 12 months

Détail du antigène

Antigène: Influenza B Virus

Classe de substances: Virus

Sujet: Influenza virus type B is a genus in the virus family Orthomyxoviridae, responsible for acute respiratory illnesses in humans. It varies antigenically from influenza virus types A and C and is not divided into any subtypes. The gradual evolution of Influenza virus type B occurs via a series of mutations known as antigenic drift, in the surface glycoprotein haemagglutinin (HA), enabling the virus to evade the immune system and potentially re-infect the same host. HA glycoproteins from the Influenza virus type B are included in the annually updated trivalent flu vaccine, along with the Influenza virus type A subtypes H3N2 and H1N1.Synonyms: Influenza B Virus